Fortitude Family Office »

Fennec Pharmaceuticals shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2026-06-30 $54 5 10.80

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Avantis Total Equity Markets Etf Etf (AVTM)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Vanguard Mid-cap Etf Etf (VO)
Apple Stock (AAPL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard S&p 500 Etf Etf (VOO)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Invesco Senior Loan Etf Etf (BKLN)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)

View all positions for Fortitude Family Office

Top funds holding Fennec Pharmaceuticals

Rosalind Advisors
AIGH Capital Management
Solas Capital Management
BlackRock
AWM Investment Company
Vanguard Capital Management
Prospect Capital Advisors
Geode Capital Management
State Street Corporation
Jane Street
Potomac Capital Management
Morgan Stanley
Vanguard Portfolio Management
Northern Trust
Marshall Wace

View all funds holding Fennec Pharmaceuticals